These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 2749609)
41. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action. Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772 [TBL] [Abstract][Full Text] [Related]
42. Bronchial and vascular effects of Paf in the rat isolated lung are completely blocked by WEB 2086, a novel specific Paf antagonist. Casals-Stenzel J; Franke J; Friedrich T; Lichey J Br J Pharmacol; 1987 Aug; 91(4):799-802. PubMed ID: 3664079 [TBL] [Abstract][Full Text] [Related]
43. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist. Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331 [TBL] [Abstract][Full Text] [Related]
44. 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity. Grigoriadis G; Stewart AG Br J Pharmacol; 1991 Sep; 104(1):171-7. PubMed ID: 1664761 [TBL] [Abstract][Full Text] [Related]
45. Cardiovascular responses to exogenous platelet-activating factor (PAF) in anesthetized ponies, and the effects of a PAF antagonist, WEB 2086. Wilson DV; Eberhart SW; Robinson NE; Rice R; Gray PR Am J Vet Res; 1993 Feb; 54(2):274-9. PubMed ID: 8430938 [TBL] [Abstract][Full Text] [Related]
46. Platelet-activating factor as an intercellular signal in neutrophil-dependent platelet activation. Zhou W; Javors MA; Olson MS J Immunol; 1992 Sep; 149(5):1763-9. PubMed ID: 1506691 [TBL] [Abstract][Full Text] [Related]
47. Antithrombotic activity of the phosphodiesterase III inhibitor pelrinone in a canine model of coronary artery thrombosis: enhancement of efficacy with concurrent alpha 2-adrenergic antagonism. Kitzen JM; McCallum JD; Harvey C; Morin ME J Cardiovasc Pharmacol; 1991 Dec; 18(6):777-90. PubMed ID: 1725888 [TBL] [Abstract][Full Text] [Related]
49. Platelet-released ADP stabilizes PAF-induced rabbit platelet aggregation by stabilizing intracellular calcium. Yi FX; Guo ZG Zhongguo Yao Li Xue Bao; 1998 Jul; 19(4):379-82. PubMed ID: 10375790 [TBL] [Abstract][Full Text] [Related]
50. PAF antagonistic activity of some thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepines. Tahara T; Mikashima H; Terasawa M; Maruyama Y Chem Pharm Bull (Tokyo); 1987 May; 35(5):2119-21. PubMed ID: 3664818 [No Abstract] [Full Text] [Related]
51. Synergistic actions of paf-acether and sodium arachidonate in human platelet aggregation. 2. Unexpected results after aspirin intake. Altman R; Scazziota A Thromb Res; 1986 Jul; 43(1):113-20. PubMed ID: 3088757 [TBL] [Abstract][Full Text] [Related]
52. Endogenous platelet activating factor does not modulate blood flow and metabolism in normal rat brain. Kochanek PM; Melick JA; Schoettle RJ; Magargee MJ; Evans RW; Nemoto EM Stroke; 1990 Mar; 21(3):459-62. PubMed ID: 2309270 [TBL] [Abstract][Full Text] [Related]
53. Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Tóth O; Calatzis A; Penz S; Losonczy H; Siess W Thromb Haemost; 2006 Dec; 96(6):781-8. PubMed ID: 17139373 [TBL] [Abstract][Full Text] [Related]
54. Effects of platelet activating factor receptor antagonists on intracellular platelet activating factor function in neutrophils. Koike H; Imanishi N; Natsume Y; Morooka S Eur J Pharmacol; 1994 Nov; 269(3):299-309. PubMed ID: 7895770 [TBL] [Abstract][Full Text] [Related]
55. Mechanisms of interaction of a plasmalogenic analog of platelet-activating factor with human platelets. Kulikov VI; Muzya GI Biochemistry (Mosc); 1999 Jun; 64(6):631-5. PubMed ID: 10395976 [TBL] [Abstract][Full Text] [Related]
56. Relaxations of guinea-pig isolated trachea induced by platelet-activating factor are epithelial-dependent and are antagonised by WEB 2086. Conroy DM; Samhoun MN; Piper PJ Eur J Pharmacol; 1990 Sep; 186(2-3):315-8. PubMed ID: 2289533 [TBL] [Abstract][Full Text] [Related]
57. The platelet-stimulating effect of adrenaline through alpha 2-adrenergic receptors requires simultaneous activation by a true stimulatory platelet agonist. Evidence that adrenaline per se does not induce human platelet activation in vitro. Steen VM; Holmsen H; Aarbakke G Thromb Haemost; 1993 Sep; 70(3):506-13. PubMed ID: 8259557 [TBL] [Abstract][Full Text] [Related]
58. Selective inhibition of adrenaline-induced human platelet aggregation by the structurally related Paf antagonist Ro 19-3704. Schattner M; Parini A; Fouque F; Vargaftig BB; Touqui L Br J Pharmacol; 1989 Apr; 96(4):759-66. PubMed ID: 2787179 [TBL] [Abstract][Full Text] [Related]
59. Evidence for an intracellular action of platelet-activating factor in bovine cultured aortic endothelial cells. Stewart AG; Dubbin PN; Harris T; Dusting GJ Br J Pharmacol; 1989 Mar; 96(3):503-5. PubMed ID: 2497920 [TBL] [Abstract][Full Text] [Related]
60. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways. Krishnamurthi S; Westwick J; Kakkar VV Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]